ES2152324T3 - Vesiculas lipidicas multilaminares bifasicas. - Google Patents

Vesiculas lipidicas multilaminares bifasicas.

Info

Publication number
ES2152324T3
ES2152324T3 ES94922214T ES94922214T ES2152324T3 ES 2152324 T3 ES2152324 T3 ES 2152324T3 ES 94922214 T ES94922214 T ES 94922214T ES 94922214 T ES94922214 T ES 94922214T ES 2152324 T3 ES2152324 T3 ES 2152324T3
Authority
ES
Spain
Prior art keywords
lipid
multilaminary
bipassic
lipid vesicles
vesicle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94922214T
Other languages
English (en)
Inventor
Marianna Foldvari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmaderm Laboratories Ltd
Original Assignee
Pharmaderm Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaderm Laboratories Ltd filed Critical Pharmaderm Laboratories Ltd
Application granted granted Critical
Publication of ES2152324T3 publication Critical patent/ES2152324T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Fats And Perfumes (AREA)

Abstract

UNA VESICULA LIPIDA MULTILAMELAR BIFASICA QUE CONSTA DE UNA PLURALIDAD DE BICAPAS LIPIDAS ESPACIADAS ENTRE SI QUE INCLUYEN UN COMPONENTE FORMADOR DE LIPOSOMAS Y OPCIONALMENTE UN AGENTE BIOLOGICAMENTE ACTIVO ATRAPADO ENTRE LAS BICAPAS LIPIDAS. LA VESICULA LIPIDA TAMBIEN CONTIENE COMPARTIMIENTOS PERIFERICOS CON UNA SOLUCION ACUOSA FORMADOS ENTRE LAS BICAPAS LIPIDAS, Y UN COMPARTIMIENTO DE NUCLEO LIPOFILICO CENTRAL SUSTANCIALMENTE EN EL CENTRO DE LA VESICULA LIPIDA MULTILAMELAR.
ES94922214T 1993-07-28 1994-07-28 Vesiculas lipidicas multilaminares bifasicas. Expired - Lifetime ES2152324T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9810293A 1993-07-28 1993-07-28

Publications (1)

Publication Number Publication Date
ES2152324T3 true ES2152324T3 (es) 2001-02-01

Family

ID=22267097

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94922214T Expired - Lifetime ES2152324T3 (es) 1993-07-28 1994-07-28 Vesiculas lipidicas multilaminares bifasicas.

Country Status (10)

Country Link
EP (1) EP0711148B1 (es)
AT (1) ATE195866T1 (es)
AU (1) AU7343894A (es)
CA (1) CA2168260C (es)
DE (1) DE69425750T2 (es)
DK (1) DK0711148T3 (es)
ES (1) ES2152324T3 (es)
GR (1) GR3034777T3 (es)
PT (1) PT711148E (es)
WO (1) WO1995003787A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0722323B1 (en) * 1994-08-05 1999-09-22 Inpharma S.A. Compositions containing troxerutine complexed with phosphatidylcholine for topical treatment of erectile impotence
US5718917A (en) * 1995-12-15 1998-02-17 Harvard Scientific Corporation PGE-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction
GB9605915D0 (en) * 1996-03-21 1996-05-22 Univ Bruxelles Liposome encapsulated amphiphilic drug compositions
US6416740B1 (en) * 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US5993852A (en) * 1997-08-29 1999-11-30 Pharmaderm Laboratories Ltd. Biphasic lipid vesicle composition for transdermal administration of an immunogen
BE1011899A6 (fr) 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.
KR20060123170A (ko) * 2003-10-24 2006-12-01 알자 코포레이션 지질 입자의 제조방법
WO2008000534A1 (de) * 2006-06-30 2008-01-03 Gertrud Langhoff Solubilisatformulierungen
EP2134353B1 (en) * 2007-03-30 2016-11-16 Helix Biopharma Corp. Biphasic lipid-vesicle composition and method for treating cervical dysplasia by intravaginal delivery
FR2939313B1 (fr) * 2008-12-10 2012-03-23 St Hubert Procede de preparation de vesicules a caractere hydrophobe comprenant une cavite interne hydrophobe.
US20120021036A1 (en) * 2009-01-15 2012-01-26 The Regents Of The University Of California Composite nanostructures and methods for making and using them
US9668474B2 (en) 2012-02-10 2017-06-06 Stepan Company Structured surfactant suspending systems
GB201202333D0 (en) * 2012-02-10 2012-03-28 Stepan Co Structured surfactant suspending systems
US10159646B2 (en) 2013-08-12 2018-12-25 Altum-Avro Pharma Partnership Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
US8986732B2 (en) 2013-08-12 2015-03-24 Helix Biopharma Corporation Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
CN107106421B (zh) * 2014-12-30 2020-10-27 赛特瑞恩股份有限公司 表皮生长因子和脂质体的混合型多层纳米结构及其制造方法
DK3512495T3 (da) 2016-09-15 2022-12-05 Camurus Ab Formuleringer af prostacyklinanaloger
EP3630067A4 (en) * 2017-05-26 2021-08-11 Altum Pharmaceuticals Inc. GIVING A BIPHASIC CANNABINOID
WO2019246286A1 (en) 2018-06-19 2019-12-26 Neon Therapeutics, Inc. Neoantigens and uses thereof
TWI848045B (zh) * 2019-01-30 2024-07-11 德商巴地斯顏料化工廠 供個人護理應用之液晶脂質顆粒之化妝品組合物
KR20220070246A (ko) 2019-09-23 2022-05-30 디디에스 리서치 인크. 침투 증진제를 갖는 지질 소포 조성물
MX2023011157A (es) 2021-03-24 2024-01-25 Glo Pharma Inc Peptidos y metodos para reducir la pigmentacion de la piel.
KR20240102989A (ko) * 2021-11-04 2024-07-03 글로 파마, 인크. 화장품 적용을 위한 방법 및 조성물
CN115531319B (zh) * 2022-11-25 2023-05-05 仙乐健康科技股份有限公司 一种高稳定性脂质体及其制备方法和用途
WO2025121442A2 (en) * 2023-12-05 2025-06-12 L'oreal Stable composition with excellent texture

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS607932A (ja) * 1983-06-29 1985-01-16 Dai Ichi Seiyaku Co Ltd リポソーム懸濁液およびその製法
US5160669A (en) * 1988-03-03 1992-11-03 Micro Vesicular Systems, Inc. Method of making oil filled paucilamellar lipid vesicles
WO1990012565A1 (en) * 1989-04-25 1990-11-01 Nattermann, A. & Cie. Gmbh Water-containing formulations with phospholipids
CA2038945A1 (en) * 1989-08-01 1991-02-02 Norman D. Weiner Topical delivery of peptides/proteins entrapped in dehydration/rehydration liposomes
WO1993000894A1 (en) * 1991-07-03 1993-01-21 Scott Nathan E Prostaglandin e2 treatment of impotence

Also Published As

Publication number Publication date
WO1995003787A1 (en) 1995-02-09
GR3034777T3 (en) 2001-02-28
ATE195866T1 (de) 2000-09-15
CA2168260A1 (en) 1995-02-09
DE69425750T2 (de) 2001-04-26
DE69425750D1 (de) 2000-10-05
PT711148E (pt) 2001-02-28
EP0711148B1 (en) 2000-08-30
EP0711148A1 (en) 1996-05-15
AU7343894A (en) 1995-02-28
CA2168260C (en) 2000-04-11
DK0711148T3 (da) 2001-01-02

Similar Documents

Publication Publication Date Title
ATE195866T1 (de) Zweiphasige multilamellare lipidvesikel
ES8603264A1 (es) Un procedimiento para coencapsular en vesiculas lipidicas una preparacion de liposoma-farmaco
DK433484D0 (da) Medikamentholdigt lipidvesikelpraeparat
FI880841L (fi) Menetelmä biologisesti aktiivisten multivesikulaaristen lipidivesikkeleiden tai liposomien valmistamiseksi
DE69530368D1 (de) Vinca-alkaloid vesikel mit erhöhter wirksamkeit und tumor-zielausrichtung
WO2001039744A3 (en) Radiation sensitive liposomes
ES2123284T3 (es) Un sistema de suministro liposomico para agentes biologicamente activos.
SG65599A1 (en) Cosmetic delivery system for salicylic acid and process for preparation of same
BR9508913A (pt) Preparação de lipossomas multivesiculares para liberação controlada de agentes ativos
ZA885450B (en) Method of manufacturing unilamellar lipid vesicles
DK1017365T3 (da) Liposomomsluttet polynukleotidsammensætning og fremgangsmåde
ATE79028T1 (de) Nystatin enthaltende liposome.
ES2134846T3 (es) Formulacion de antibiotico y uso para infecciones resistentes a farmacos.
PL334940A1 (en) Lipoid complexes and liposomes of highly insoluble platinum complexes
HU9601476D0 (en) Process for echancing the stability of liposomal suspensions containing hydrophilic active agents
ATE226843T1 (de) Mittel zur tumortherapie auf liposomenbasis, die tamoxifen enthalten
GB2303791B (en) Method of preparing a predetermined active agent stock solution for liposomal microencapsulation of active agents for agricultural uses
ATE199315T1 (de) Liposomzubereitungen enthaltend hybrid-interferon
SI0711148T1 (en) Biphasic multilamellar lipid vesicles
GB2329124B (en) Method of forming dose units of active agents
FI970935A0 (fi) Terapeutiskt anvaendbara eterlipider och foerfaranden foer deras framstaellning
ES8600055A1 (es) Un procedimiento para coencapsular en vesiculas lipidicas una preparacion de liposoma-farmaco.
GB9407327D0 (en) Biologically and therapeutically active agents against HIV-1 T

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 711148

Country of ref document: ES